30424002: Proxymetacaine hydrochloride (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anesthetic (substance)\Local anesthetic (substance)\Benzoic acid ester local anesthetic\Proxymetacaine hydrochloride (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Benzoic acid and/or benzoic acid derivative (substance)\Benzoate derivative (substance)\Benzoic acid ester and/or benzoic acid ester derivative (substance)\Benzoic acid ester local anesthetic\Proxymetacaine hydrochloride (substance)

\Ester\Benzoic acid ester and/or benzoic acid ester derivative (substance)\Benzoic acid ester local anesthetic\Proxymetacaine hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

50926019 Proparacaine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4688959017 Proxymetacaine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4688960010 Proxymetacaine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4488401000241112 chlorhydrate de proparacaïne fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Proxymetacaine hydrochloride (substance)	Is a	Proparacaine	false	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	Is a	Proxymetacaine (substance)	false	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	Is a	Proparacaine	false	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	Is a	Proxymetacaine (substance)	false	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Proxymetacaine (substance)	true	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	Is a	Ester	false	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	Is a	Local anesthetic (substance)	false	Inferred relationship	Some
Proxymetacaine hydrochloride (substance)	Is a	Benzoic acid ester local anesthetic	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Proparacaine hydrochloride 0.5% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some
Proparacaine hydrochloride 0.5%vv solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some
Proparacaine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some
Proxymetacaine hydrochloride 0.5% single-use eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some
Proxymetacaine hydrochloride 0.5% conventional release eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some
Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some	2
Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some	2
Product containing precisely proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Proxymetacaine hydrochloride (substance)	Inferred relationship	Some	1

This concept is not in any reference sets